Isentress (raltegravir or RAL) is an integrase inhibitor used to treat HIV/AIDS. It is approved by the U.S. FDA for the treatment of HIV infection in patients 4 weeks of age and older. It is listed in the HHS HIV treatment guidelines as part of a recommended regimen for people starting HIV treatment for the first time, when taken in combination with Truvada.
Adult single dose: Take one 400-mg tablet twice daily.
The content on this page is free of advertiser influence and was produced by our editorial team. See our advertising policy.